Molecular mechanism of insulin resistance in human obesity

Current Opinion in Endocrinology and Diabetes

Volumn 3, Issue 1, 1996, Pages 36-43

  Kolaczynski, Jerzy W ^a   Caro, Jose F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005915846     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199602000-00007     Document Type: Article

References (76)

1. Caro JF: Clinical review 26: insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 1991, 73:691-695.
2. Long SD, O'Brien K, McDonald KG Jr, Leggett-Frazier N, Swanson MS, Portes WJ, Caro JF: Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes: a longitudinal interventlonal study. Diabetes Care 1994, 17:372-375. Weight loss achieved by bariatric surgery in patients with clinically severe obesity prevents the progression of impaired glucose tolerance to diabetes by more than 30-fold.
3. Pories WJ, MacDonald KG, Morgan EJ, Sinha MK, Dohm GL, Swanson MS, Barakat HA, Khazanie PG, Leggett-Frazier N, Long SD, O'Brien KF, Caro JF: Surgical treatment of obesity and Its effect on diabetes: 10-y follow-up. Am J Clin Nutr 1992, 55:582s-585s.
4. Bouchard C, Perusse L, LeBlanc C, Tremlay A, Theriault G: Inheritance of the amount and distribution of human body fat. Int J Obes Relat Metab Disord 1988, 12:205-215.
5. Zhang Y, Porenca R, Mattei M, Barone M, Leopold L, Friedman JM: Positioning cloning of the mouse obese gene and Its human homologue. Nature 1994, 372:425-432.
6. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269:540-543. Administration of leptin to ob/ob mice causes reduction of food intake, weight loss, and dramatic reduction in insulin resistance.
7. Sims EA, Danforth E, Norton ES, Bray GA, Glennon JA, Salans LB: Endocrine and metabolic effects on experimental obesity in man. Recent Prog Horm Res 1973, 29:457-496.
8. Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ, Therriault G, Dussault J, Moorjani S, Pinault S, Foumier G: The response to long-term overfeeding in Identical twins. N Engl J Med 1990, 322:1477-1482.
9. Caro JF, Ittoop O, Pories WJ, Meelheim D, Flickinger EG, Thomas F, Jenguin M, Silverman JF, Khazanie PG, Sinha MK: Studies of the mechanism of insulin resistance in the liver from humans with noninsulin dependent diabetes. J Clin Invest 1983, 78:249-258.
10. Olefsky JM: Insulin resistance and insulin action. Diabetes 1981, 30:148-153.
11. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm GL: Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 1987, 91:330-337.
12. Seino S, Seino M, Bell G: Human Insulin-receptor gene. Diabetes 1990, 39:129-133.
13. Seino S, Bell GI: Alternate splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 1989, 159:312-316.
14. McClain DA: Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol Endocrinol 1991, 5:734-739.
15. Benecke H, Flier JS, Moller DE: Alternatively spliced variants of the insulin receptor protein. J Clin Invest 1992, 89:2066-2070.
16. Anderson CM, Henry RR, Knudson PE, Olefsky JM, Webster NJG: Relative expression of insulin receptor isoforms does not differ in lean, obese, and noninsulin-dependent diabetes mellitus subjects. J Clin Endocrinol Metab 1993, 76:1380-1382.
17. White MF, Kahn CR: Molecular aspects of insulin action. In Joslin's Diabetes Mellitus. edn 13. Edited by Kahn CR, Weir GC. Philadelphia: Lea and Febiger; 1994:136-162.
18. Cama A, de la Luz Sierra M, Ottini L, Kadowaki T, Gorden P, Imperato-McGinley J, Taylor S: A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. J Clin Endocnnol Metab 1991, 73:894.
19. White MF, Shoelson SE, Keutmann H, Kahn CR: A cascade of tyrosine autophosphorylation in the beta subunit activates the phosphotransferase of the insulin receptor. J Biol Chem 1992, 263:2969-2989.
20. Widen PA, Siddle K, Haring E, Backer JM, White MF, Kahn CR: The role of insulin receptor kinase domain autophosphorylation in receptor mediated activities: analysis with insulin and anti-receptor antibodies. J Biol Chem 1992, 264:13719-13723.
21. Issad T, Tavare JM, Denton RM: Analysis of insulin receptor phosphorylation sites in intact rat liver cell by two-dimensional phosphopeptide mapping: predominance of the tris-phosphorylated form of the kinase domain after stimulation by insulin. Biochem J 1991, 275:15-21.
22. Ahmad F, Considine RV, Goldstein BJ: Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J Clin Invest 1994, 95:2806-2812. Abundance of phosphatase LAR in adipose tissue correlates with body-mass index.
23. Goldstein BJ: Regulation of insulin receptor signalling by protein-tyrosine dephosphorylation. Receptor 1993, 3:1-15.
24. Fischer EH, Charbonneau H, Tonks NK: Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 1994, 253:401-406.
25. Freidenberg GR, Reichart D, Olefsky JM, Henry RR: Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellltus. J Clin Invest 1988, 82:1398-1406.
26. Sinha MK, Pories WJ, Flickinger EG, Meelheim O, Caro JF: Insulin receptor kinase activity of adipose tissue from morbidly obese humans with or without NIDDM. Diabetes 1987, 36:620-625.
27. Freidenberg GR, Henry RR, Klein HH, Reichart DR, Olefsky JM: Decreased kinase activity of insulin receptors from adipocytes of non-insulin dependent diabetic subjects. J Clin Invest 1987, 79:240-250.
28. Caro JF, Itop O, Pories WJ, Meelheim D, Flickinger EG, Thomas F, Jenquin M, Silverman JF, Khazanie PG, Sinha MK: Studies on the mechanism of insulin resistance in the liver from humans with non-insulin-dependent diabetes: insulin action and binding in isolated hepatocytes, insulin receptor structure and kinase activity. J Clin Invest 1986, 78:249-258.
29. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL: Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-klnase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 1995, 95:2195-2204. Study documenting that the major molecular defect in isolated skeletal muscle from insulin-resistant obese individuals is the 1RS-1-induced stimulation of PI-3 kinase activity.
30. Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky JM: Role of human skeletal muscle insulin receptor kinase in in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 1994, 78:471-477.
31. Myers MG, Backer JM, Siddle K, White MF: The insulin receptor functions normally in Chinese hamster ovary cells after truncation of the C-terminus. J Biol Chem 1991, 266:10616-10623.
32. Thies RS, Ullrich A, McClain DA: Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor. J Biol Chem 1989, 264:12820-12825.
33. Yamamoto-Honda R, Kadowaki T, Momomura K, Tobe K, Tamori Y, Shibasaki Y, Mon Y, Kaburagi Y, Koshio O, Akanuma Y, Yazaki Y, Kasuga M: Normal insulin receptor substrate-1 phosphoryiation in autophosphorylation-defective truncated insulin receptor: evidence that phosphorylation of substrates might be sufficient for certain biological effects evoked by insulin. J Biol Chem 1993, 268:16859-16865.
34. White MF, Maron R, Kahn CR: Insulin rapidly stimulates tyrosine phosphorylation of a Mr 185,000 protein in intact cells. Nature 1985, 318:183-186.
35. Shoelson SE, Chattarjee S, Chaudhuri M, White MF: YMXM motifs of IRS-1 define the substrate specificity of the insulin receptor kinase. Proc Natl Acad Sci U S A 1992, 89:2027-2031.
36. Thies RS, Molina JM, Ciaraldi TP, Freidenberg GR, Olefsky JM: Insulin-receptor autophosphorylation and endogenous substrate phosphoryiation in human adipocytes from control, obese and NIDDM subjects. Diabetes 1990, 39:250-259.
37. Backer JM, Schroeder GG, Kahn CR, Meyers PA, Wilden DA, Cahill DA, White MF: Insulin stimulation of phosphatidylinositol 3-kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation. J Biol Chem 1992, 267:1367-1374.
38. Kelly KL, Ruderman NB, Chen KS: Phosphatidylinositol-3-kinase in isolated rat adipocytes: activation by insulin and subcellular distribution. J Biol Chem 1992, 267:3423-3428.
39. Folli FM, Saad JA, Backer JM, Kahn CR: Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate-1 in liver and muscle of the intact rat. J Biol Chem 1992, 267:22171-22177.
40. Chen KS, Friel JC, Ruderman NB: Regulation of phosphatidylinositol 3-kinase by insulin in rat skeletal muscle. Am J Physiol 1993, 265:E736-E743.
41. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR: Phosphatidylinosltol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis and glucose transporter translocation. Mol Cell Biol 1994, 14:4902-4911.
42. Clarke JF, Young PW, Yonezawa K, Kasuga M, Holman GD: Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J 1994, 300:631-635.
43. Kanal F, Ito K, todaka M, Hayashi H, Kamohara S, Ishii K, Okada T, Hazeki O, Ui M, Ebina Y: Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. Biochem Biophys Res Commun 1993, 185:762-768.
44. Caro JF: Biochemical defects of insulin action in humans. In Diabetes Mellitus: A Fundamental and Clinical Text. Philadelphia: Mosby-Year Book, in press.
45. Caro JF, Raju MS, Caro M, Lynch CL, Poulos J, Exton JH, Thakkar JK: Guanine nucleotide binding regulatory protein in liver from obese humans with and without type II diabetes: evidence for altered cross-talk between insulin receptor and Gi-proteln. J Cell Biochem 1994, 54:309-319. Evidence for the cross-talk between insulin receptor and G proteins.
46. Considine RV, Caro JF: Protein kinase C: mediator or inhibitor of insulin action? J Cell Biochem 1993, 52:8-13.
47. Considine RV, Nyce MR, Allen LE, Moralez LM, Triester S, Serrano J, Colberg J, Lanza-Jacoby S, Caro JF: Protein kinase C is increased in the liver of humans and rats with non-insulin dependent diabetes mellitus: an alteration not due to hyperglycemia. J Clin Invest 1995, 95:2938-2944. Protein kinase C is elevated in patients with NIDDM and less so in obese normoglycemic individuals.
48. Oelbaum RS: Analysis of three glucose transporter genes in a Caucasian population: no associations with non-insulin-dependent diabetes and obesity. Clin Genet 1992, 42:260-266.
49. Fukumoto H, Kayano T, Buse JB, Edwards Y, Pilch PF, Bell GI, Seino S: Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues. J Biol Chem 1989, 264:7776-7779.
50. James DE, Strube M, Mueckler M: Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 1989, 338:83-87.
51. Garvey WT, Maianu L, Hancock JA, Golichowski AM, Baron A: Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity. IGT, GDM, and NIDDM. Diabetes 1992, 41:465-475.
52. Kahn B, Pederson O: Tissue specific regulation of glucose transporters in different forms of obesity. Proc Soc Exp Biol Med 1992, 200:214-217.
53. Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM, Ciraldi TP: Pretranslational suppression of glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest 1991, 87:1072-1081.
54. Giacchetti G, Faloia E, Taccaliti A, Morosini PP, Arnaldi G, Soleti F, Mantero F, Accili D, DePirro R: Decreased expression of Insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulln-dependent diabetic and obese patients: evaluation by a simplified quantitative PCR assay. J Endocrinol Invest 1994, 17:709-715.
55. Garvey TW, Huecksteady TP, Matthaei S, Olefsky JM: Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. J Clin Invest 1988, 81:1528-1536.
56. Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM, Ciraldi TP: Pretranslational suppression of glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin dependent diabetes mellitus and obesity. J Clin Invest 1991, 87:1072-1081.
57. Kandror KV, Pilch PF: Gp160, a tissue-specific marker for insulin-activated glucose transport. Proc Natl Acad Sci U S A 1994, 91:8017-8021.
58. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994, 331:1188-1193. Troglitazone improves insulin sensitivity independent of weight loss and changes in physical activity.
59. Carey JO, Azevedo JL, Morris PG, Pories WJ, Dohm GL: Okadalc acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle. Diabetes 1996, in press.
60. Friedman JE, Dohm GL, Elton CW, Tapscott EB, Pories WJ, Caro JF: Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. J Clin Invest 1992, 89:701-707.
61. Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 1995, 44:1121-1125.
62. Campbell PJ, Gerich JE: Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of threshold for the adverse effect of obesity. J Clin Endocrinol Metab 1990, 70:1114-1118.
63. Ruderman NB: Role of insulin resistance to human disease. Diabetes 1988, 37:1595-1607.
64. Swinburn BA, Nyomba BL, Saad MF, Zurto F, Raz I, Knowler WC, Lillioja S, Bogartus C, Ravusin E: Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991, 88:168-173.
65. Odeleye OE, De Courten M, Ravussin E: Insulin resistance as a predictor of body weight gain in 5-10 year old Pima Indians. Diabetes 1995, 44(suppl 1):7a. In contradiction to the initial report by Swinburn et al. (J Clin Invest 1991, 88:168-173), the authors find that insulin resistance, at least among children 5 to 10 years of age, is a predictor of weight gain in later age.
66. Odeleye OE, De Courten M, Ravussin E: Insulin resistance as a predictor of body weight gain in 5-10 year old Pima Indians. Diabetes 1995, 44(suppl 1):7a. In contradiction to the initial report by Swinburn et al. (J Clin Invest 1991, 88:168-173), the authors find that insulin resistance, at least among children 5 to 10 years of age, is a predictor of weight gain in later age.
67. Jeanrenaud B: Central nervous system and peripheral abnormalities: clues to the understanding of obesity and NIDDM. Diabetologia 1994, 37(suppl 2):S169-S178.
68. Felber JP, Haesler E, Jéquier E: Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1993, 36:1221-1229.
69. Tappy L, Felber JP, Jéquier E: Energy and substrate metabolism in obesity and postobese state. Diabetes Care 1990, 14:1180-1188.
70. Boden G, Jadali F, White J: Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 1991, 88:960-966.
71. Zurlo F, Ullioja S, Puente AE, Nyomba BL, Raz I, Saad MF, Swinburn BA, Knowler WC, Bogartus C, Ravussin E: Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RO. Am J Physiol 1990, 259:E650-E657.
72. Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbot WGH, Boyce V, Howard BV, Bogartus C: Reduced rate of energy expenditure as risk factor for body weight gain. N Engl J Med 1988, 318:467-472.
73. Van Etten LMLA, Westerterp KR, Vestarppen FTJ: Effect of weight training on energy expenditure and substrate utilization during sleep. Med Sci Sports Exerc 1995, 27:188-193. A fascinating report that exercise training contributes to the increased oxidation of fat during the night hours.
74. Ravussin E, Swinburn BA: Pathophyslology of obesity. Lancet 1992, 340:404-408.
75. Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, Bauer TL, Rosato EL, Caro JF: Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995, 95:2986-2988. No evidence for defective ob gene in obese humans.
76. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco SC, McKee L, Bauer TL, Caro JF: The protein product of Ob gene Is elevated in human obesity: effect of weight loss, fasting and feeding. N Engl J Med 1996, in press. The elevation of leptin levels in the serum as measured by the developed radioimmunoassay correlates with the percentage of body fat. There are no significant oscillations between fasting and postprandial leptin levels.